GLP-1 Meal Plan - What to Eat on Ozempic, Mounjaro, Wegovy, and Retatrutide
GLP-1 receptor agonist medications - semaglutide (sold as Ozempic and Wegovy), tirzepatide (sold as Mounjaro), and the newer retatrutide - have changed the weight loss landscape in the UK. Originally developed for type 2 diabetes, they are now widely prescribed and privately obtained for weight management. Retatrutide, a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, is currently in late-stage clinical trials and showing even greater weight loss results than its predecessors. They all work, often dramatically. But the medication is only half the equation. What you eat while taking them determines whether you lose mostly fat or lose a dangerous amount of muscle along with it.
This guide covers how GLP-1 medications affect your appetite and digestion, why nutrition matters more on these drugs than off them, what to eat to protect your health while losing weight, and how to structure your meals when your appetite has practically disappeared.
How GLP-1 Medications Work
GLP-1 (glucagon-like peptide-1) is a hormone your body produces naturally in the gut after eating. It signals to your brain that you are full, slows the rate at which your stomach empties, and helps regulate blood sugar by stimulating insulin release. GLP-1 medications mimic this hormone at much higher levels than your body produces naturally.
The result is a significant reduction in appetite. Most people on these medications simply do not feel hungry. Food becomes less interesting. Portions that previously felt normal now feel enormous. Cravings for high-calorie foods diminish. Clinical trials for semaglutide 2.4mg (Wegovy) published in the New England Journal of Medicine by Wilding et al. (2021) showed an average weight loss of 14.9% of body weight over 68 weeks. Tirzepatide trials (SURMOUNT-1) published in the same journal by Jastreboff et al. (2022) showed even greater results - up to 22.5% weight loss at the highest dose. Early phase 2 trial data for retatrutide, published by Jastreboff et al. (2023) in the NEJM, showed weight loss of up to 24.2% at 48 weeks - and this is expected to increase in longer trials. As these medications get more powerful, the nutritional challenges they create become even more important to address.
These are remarkable numbers. But they come with a nutritional challenge that too many people overlook.
The Muscle Loss Problem
When you lose weight rapidly on any diet or medication, you do not just lose fat. You lose muscle too. This is a well-established phenomenon, but GLP-1 medications make it worse because they suppress appetite so aggressively that many people drastically under-eat - particularly protein.
A study by Wilding et al. published alongside the Wegovy trial data showed that approximately 40% of the weight lost was lean mass (muscle, bone, water) rather than fat. That is a significant amount of muscle to lose. Muscle is metabolically active tissue - it burns calories at rest, supports your joints, protects against falls and injuries, and is critical for long-term health. Losing large amounts of muscle while losing fat is not a good outcome, even if the scales look impressive.
The term "Ozempic body" has entered popular conversation to describe people who have lost a lot of weight on these medications but look gaunt, weak, or unhealthy because they lost too much muscle. This is not an inevitable side effect of the medication. It is a consequence of poor nutrition while taking it.
Why Protein Is Non-Negotiable on GLP-1 Medications
The single most important nutritional priority while taking a GLP-1 medication is protein intake. Without enough protein, your body cannot maintain muscle mass during rapid weight loss. With enough protein - combined with resistance training - you can significantly shift the ratio of fat loss to muscle loss in your favour.
A study published in Obesity by Mesinovic et al. (2023) found that higher protein intake during weight loss was associated with greater preservation of lean mass. The International Society of Sports Nutrition recommends 1.6 to 2.2g of protein per kilogram of body weight for muscle maintenance during calorie restriction. For most people on GLP-1 medications, a practical minimum target is 1.2 to 1.6g per kilogram of body weight per day.
For a 90kg person, that is 108 to 144g of protein per day. For a 75kg person, that is 90 to 120g. When your appetite is suppressed and you are eating 1,200 to 1,500 calories a day, hitting those numbers requires deliberate planning. You cannot just eat whatever you feel like and hope to get enough protein by accident. If you want to understand more about protein and why it is so important, our complete protein guide covers it in detail.
What to Eat on GLP-1 Medications
The challenge is simple: you need to get maximum nutrition from minimum volume. Your appetite is low, your stomach empties slowly, and large meals may cause nausea. Every bite needs to count.
Prioritise Protein at Every Meal
Start every meal with protein. If you eat the carbohydrates and vegetables first and get full before reaching the chicken, you have missed the most important part. Eat the protein first, then fill in around it.
Good protein sources that work well with reduced appetite include chicken breast, turkey mince, white fish (cod, haddock, sea bass), eggs, Greek yoghurt, cottage cheese, and protein shakes. These are all relatively easy to digest and high in protein relative to their volume.
A protein shake can be particularly useful on days when eating solid food feels difficult. It delivers 30 to 40g of protein in liquid form, which many people find easier to tolerate than a full meal.
Eat Smaller, More Frequent Meals
Three large meals a day may not work while your stomach is emptying slowly. Four to five smaller meals of 300 to 400 calories each are often better tolerated and make it easier to spread your protein intake across the day. Research from the University of Texas by Mamerow et al. (2014) showed that distributing protein evenly across meals resulted in 25% greater muscle protein synthesis than eating most of your protein in one sitting.
Do Not Skip Meals
Many people on GLP-1 medications simply forget to eat because they do not feel hungry. This is dangerous. Skipping meals means missing protein, missing micronutrients, and accelerating muscle loss. Even if you are not hungry, you need to eat. Set reminders on your phone if necessary. Treat eating as part of your medication protocol, not something optional.
Include Nutrient-Dense Carbohydrates and Fats
While protein is the priority, you still need carbohydrates for energy and fats for hormone production and vitamin absorption. Choose nutrient-dense sources - sweet potatoes, rice, oats, avocado, olive oil, nuts, and seeds. Avoid filling up on empty calories from sugary drinks, crisps, or processed snacks that take up stomach space without delivering nutrition.
If you are not sure how to balance your protein, carbohydrates, and fats, our guide on what macros are and how to track them explains it simply.
Managing Common Side Effects Through Diet
Nausea: This is the most common side effect, particularly in the first few weeks and after dose increases. Eating smaller meals, avoiding greasy or fried food, eating slowly, and not lying down immediately after eating all help. Ginger tea and peppermint tea may also reduce nausea. If nausea is severe, focus on bland, easy-to-digest foods - plain rice, toast, chicken breast, bananas - until it settles.
Constipation: GLP-1 medications slow gastric emptying, which can cause constipation. Increasing fibre intake gradually (vegetables, wholegrains, legumes), drinking at least 2 litres of water per day, and staying physically active all help. If constipation persists, speak to your prescriber.
Fatigue: Often caused by under-eating rather than the medication itself. If you are eating 800 to 1,000 calories a day because you have no appetite, fatigue is inevitable. Aim for at least 1,200 to 1,500 calories minimum, with adequate protein and carbohydrates. If you are training (which you should be), you may need more.
Food aversions: Many people develop sudden aversions to foods they previously enjoyed - often meat, eggs, or dairy. If this happens, find alternative protein sources. Fish, Greek yoghurt, protein shakes, tofu, and lentils can fill the gap. The aversions often pass as your body adjusts to the medication.
A Realistic Day of Eating on GLP-1 Medication
Here is what a day might look like at roughly 1,400 calories with 120g of protein - a reasonable setup for someone on a GLP-1 medication who weighs around 80 to 90kg:
Breakfast - 300 calories, 30g protein: Our High Protein Overnight Oats - 30g+ protein, ready to eat from the fridge. Easy to digest first thing and does not require cooking when your motivation is low.
Lunch - 400 calories, 35g protein: A meal from the Meal Builder - chicken or fish with rice and vegetables. The macros are already counted, so you know exactly how much protein you are getting without weighing or tracking anything.
Afternoon - 200 calories, 25g protein: Greek yoghurt (200g) with a small handful of berries. High protein, easy on the stomach, and something you can eat even when appetite is low.
Dinner - 400 calories, 30g protein: Another Macro Based Diet meal. When your appetite is suppressed and cooking feels like too much effort, having a balanced meal ready to heat in three minutes removes the temptation to skip dinner entirely.
Evening - 100 calories, 10g protein: A small protein shake if you are short on your daily target. Liquid calories are easier to get down when solid food feels like a chore.
Daily total: approximately 1,400 calories, 120g protein. Every eating occasion includes protein. Nothing requires significant preparation. The structure works even on days when you have zero appetite - which on GLP-1 medication is most days.
The Importance of Resistance Training
Diet alone is not enough to protect muscle mass during GLP-1-assisted weight loss. You need resistance training. A study by Batsis and Villareal (2018) published in the Journal of Clinical Investigation found that combining calorie restriction with resistance training preserved significantly more lean mass than calorie restriction alone.
You do not need to train like a bodybuilder. Two to three sessions per week of full-body resistance training - squats, lunges, presses, rows, deadlifts - is enough to send the signal to your body that muscle needs to be kept. Combined with adequate protein, this shifts your weight loss heavily towards fat loss rather than muscle loss.
If you are new to resistance training, consider working with a qualified personal trainer for the first few sessions to learn proper form. The investment pays for itself in health outcomes.
When to Seek Medical Advice
GLP-1 medications are prescription drugs with real side effects. Always work with your prescriber and report any persistent or severe symptoms. Signs that you need medical attention include severe nausea or vomiting that prevents you from eating for more than 24 hours, signs of pancreatitis (severe abdominal pain radiating to the back), significant hair loss (which can indicate severe nutritional deficiency), and rapid weight loss exceeding 1kg per week consistently.
This guide is about nutrition, not medical advice. Your prescriber manages your medication. Your job is to make sure that while the medication reduces your appetite, you still give your body the nutrients it needs to stay healthy, strong, and functional - not just lighter.
For more on setting up your nutrition for fat loss specifically, our calorie deficit meals guide covers the fundamentals.
References
- Wilding et al. (2021) - Once-weekly semaglutide in adults with overweight or obesity (NEJM)
- Jastreboff et al. (2022) - Tirzepatide once weekly for the treatment of obesity (NEJM)
- Mesinovic et al. (2023) - Protein intake and lean mass preservation during energy restriction (Obesity)
- Mamerow et al. (2014) - Dietary protein distribution and muscle protein synthesis (Journal of Nutrition)
- Batsis and Villareal (2018) - Sarcopenic obesity in older adults (Journal of Clinical Investigation)
- Jastreboff et al. (2023) - Triple-hormone-receptor agonist retatrutide for obesity (NEJM)
- NICE - Semaglutide for managing overweight and obesity (NICE)
